Skip to content

Celcuity CELC EPS (Diluted)

EPS (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
$8.26+170%
Gilead Sciences logo
Gilead SciencesGILD
$1.61+54.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$0.84+4.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$0.41+10.9%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$0.53-1.9%
CG Oncology logo
CG OncologyCGON
-$0.71-57.8%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's EPS (diluted)?
Celcuity (CELC) reported EPS (diluted) of -$0.97 in Q1 2026.
How has Celcuity's EPS (diluted) changed year-over-year?
Celcuity's EPS (diluted) decreased by 12.8% year-over-year, from -$0.86 to -$0.97.
What is the long-term trend for Celcuity's EPS (diluted)?
Over 4 years (2021 to 2025), Celcuity's EPS (diluted) has grown at a 14.6% compound annual growth rate (CAGR), from -$2.20 to -$3.80.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.